Certificates of Analysis are generated for every production run to ensure scientific integrity
Yen, Head of the Laboratory of Hormonal Regulation at Duke-NUS' Cardiovascular & Metabolic Disorders Programme, and senior author of the study, said, "The potential for using vitamin B12 and folate, which have high safety profiles and are designated as dietary supplements by the US Food and Drug Administration, as first-line therapies for the prevention and treatment of NASH could result in tremendous cost savings and reduce the health burden from NASH in both developed and developing countries." Currently, the only treatment for patients with end-stage liver disease is to receive a transplant
This product is for in-vitro research use only
Clinical studies confirm that chronic treatment with AOD9604 showed no adverse effect on insulin sensitivity, making it a metabolically selective approach to body composition optimization under medical supervision
This is crucial for patients who cannot absorb B12 through normal dietary means
Unlike its predecessor Semaglutide (which only targets GLP-1), Tirzepatide showed 57% more weight loss in clinical trials
